RxDoctor Payments Data

Heather Choat

Pediatric Endocrinology · Dothan, ALNPI 1750729737

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.8% of the total across 180 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,116 and has fallen 71.4% since, to $319 in 2025.

$3,297in general payments, 2019–2025

Across 180 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$465
  • QOL Medical, LLC$353
  • Xeris Pharmaceuticals, Inc.$284
  • Biomarin Pharmaceutical Inc.$223
  • Insulet Corporation$190
  • AbbVie$190
  • plus $2K from 32 others

What the payments were for

  • Food & beverage$2,99491%
  • Education$3039%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,297 in reported general payments places this provider in the 70th percentile of 22 pediatric endocrinology providers in Alabama.

See all pediatric endocrinology providers in Alabama

Other pediatric endocrinology in Dothan

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →